Literature DB >> 29296980

Hybrid FePt/SiO2/Au nanoparticles as a theranostic tool: in vitro photo-thermal treatment and MRI imaging.

N Kostevšek1, I Abramovič, S Hudoklin, M E Kreft, I Serša, A Sepe, J Vidmar, S Šturm, M Spreitzer, J Ščančar, S Kobe, K Žužek Rožman.   

Abstract

We have produced an innovative, theranostic material based on FePt/SiO2/Au hybrid nanoparticles (NPs) for both, photo-thermal therapy and magnetic resonance imaging (MRI). Furthermore, a new synthesis approach, i.e., Au double seeding, for the preparation of Au nanoshells around the FePt/SiO2 cores, is proposed. The photo-thermal and the MRI response were first demonstrated on an aqueous suspension of hybrid FePt/SiO2/Au NPs. The cytotoxicity together with the internalization mechanism and the intracellular fate of the hybrid NPs were evaluated in vitro on a normal (NPU) and a half-differentiated cancerous cell line (RT4). The control samples as well as the normal cell line incubated with the NPs showed no significant temperature increase during the in vitro photo-thermal treatment (ΔT < 0.8 °C) and thus the cell viability remained high (∼90%). In contrast, due to the high NP uptake by the cancerous RT4 cell line, significant heating of the sample was observed (ΔT = 4 °C) and, consequently, after laser irradiation the cell viability dropped significantly to ∼60%. These results further confirm that the hybrid FePt/SiO2/Au NPs developed in the scope of this work were not only efficient but also highly selective photo-thermal agents. Furthermore, the improvement in the contrast and the easier distinction between the healthy and the cancerous tissues were clearly demonstrated with in vitro MRI experiments, proving that hybrid NPs have an excellent potential to be used as contrast agents.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29296980     DOI: 10.1039/c7nr07810b

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  6 in total

Review 1.  Heterometallic nanomaterials: activity modulation, sensing, imaging and therapy.

Authors:  Shan-Shan Li; Ai-Jun Wang; Pei-Xin Yuan; Li-Ping Mei; Lu Zhang; Jiu-Ju Feng
Journal:  Chem Sci       Date:  2022-04-12       Impact factor: 9.969

2.  Magneto-Liposomes as MRI Contrast Agents: A Systematic Study of Different Liposomal Formulations.

Authors:  Nina Kostevšek; Calvin C L Cheung; Igor Serša; Mateja Erdani Kreft; Ilaria Monaco; Mauro Comes Franchini; Janja Vidmar; Wafa T Al-Jamal
Journal:  Nanomaterials (Basel)       Date:  2020-05-06       Impact factor: 5.076

3.  Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing.

Authors:  Larisa Tratnjek; Nadica Sibinovska; Slavko Kralj; Darko Makovec; Katja Kristan; Mateja Erdani Kreft
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

4.  Magnetically guided theranostics: montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment.

Authors:  Ming-Hsien Chan; Chih-Ning Lu; Yi-Lung Chung; Yu-Chan Chang; Chien-Hsiu Li; Chi-Long Chen; Da-Hua Wei; Michael Hsiao
Journal:  J Nanobiotechnology       Date:  2021-10-09       Impact factor: 10.435

5.  Novel Methacrylate-Based Multilayer Nanofilms with Incorporated FePt-Based Nanoparticles and the Anticancer Drug 5-Fluorouracil for Skin Cancer Treatment.

Authors:  Kristijan Skok; Tanja Zidarič; Kristjan Orthaber; Matevž Pristovnik; Nina Kostevšek; Kristina Žužek Rožman; Sašo Šturm; Lidija Gradišnik; Uroš Maver; Tina Maver
Journal:  Pharmaceutics       Date:  2022-03-22       Impact factor: 6.525

Review 6.  Novel monodisperse FePt nanocomposites for T2-weighted magnetic resonance imaging: biomedical theranostics applications.

Authors:  Zhi-Xuan Chang; Chien-Hsiu Li; Yu-Chan Chang; Chi-Ying F Huang; Ming-Hsien Chan; Michael Hsiao
Journal:  Nanoscale Adv       Date:  2021-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.